Meg Jardine's Publications
About Meg Jardine's Publications
Honorary Professorial Fellow, The George Institute for Global Health- Associate Professor, Faculty of Medicine, UNSW Sydney
-
Interventions for lowering plasma homocysteine levels in dialysis patients
Cochrane Database of Systematic Reviews Date published: -
MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS
Nephrology Dialysis Transplantation Date published: -
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Cochrane Database of Systematic Reviews Date published: -
Survival outcomes of supportive careversusdialysis therapies for elderly patients with end-stage kidney disease: A systematic review and meta-analysis
Nephrology Date published: -
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score
Diabetes, Obesity and Metabolism Date published: -
Canagliflozin (CANA) Slows Progression of Renal Function Decline Independent of Glycemic Effects
Date published: -
EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS
Date published: -
EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS
Date published: -
ASSOCIATION OF NEUROPATHY AND PHYSICAL PARAMETERS IN PEOPLE ON MAINTENANCE HAEMODIALYSIS: A PROSPECTIVE STUDY
Date published: -
IS IMMUNOSUPPRESSIVE THERAPY BENEFICIAL FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SYSTEMATIC REVIEW AND TRIAL SEQUENTIAL ANALYSIS OF PUBLISHED TRIALS
Date published: -
Canagliflozin slows progression of renal function decline independent of glycaemic effects
Date published: -
THE OXFORD CLASSIFICATION SYSTEM (MEST) IN IGA NEPHROPATHY (IGAN): READY FOR ROUTINE CLINICAL PRACTICE?
Date published: -
TRENDS IN THE RELATIVE SURVIVAL OF MIDDLE AGED AND OLDER PEOPLE ON DIALYSIS IN AUSTRALIA
Date published: -
TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION
Date published: -
Renal effects of canagliflozin in type 2 diabetes mellitus
Current Medical Research and Opinion Date published: -
First Light After the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial
American Journal of Kidney Diseases Date published:
